Target intelligence / Profile preview

Multiple tissue and immune cell populations in injured myocardium

Molecular classification
Other
01

Overview

The term Multiple tissue and immune cell populations in injured myocardium refers to the complex and dynamic cellular landscape that emerges in the heart following an insult, such as myocardial infarction or myocarditis. This environment is characterized by the interaction of resident cells—including cardiomyocytes, fibroblasts, and endothelial cells—with a diverse array of infiltrating immune cells such as neutrophils, monocytes, macrophages, and T-lymphocytes (Source: Nature Cardiovascular Research, 2022). These populations collectively orchestrate the transition from an initial pro-inflammatory phase to a reparative phase involving scar formation and tissue remodeling (Source: Circulation, 2020). While this cellular milieu contains numerous individual proteins and receptors that serve as therapeutic targets, the phrase itself describes a biological context or microenvironment rather than a single druggable molecule. Modern research often employs single-cell RNA sequencing and spatial transcriptomics to map these populations and identify specific molecular drivers of heart failure progression (Source: JACC: Basic to Translational Science, 2021).

Other names
Cardiac immune microenvironmentPost-injury myocardial cellular landscapeInjured heart cell populationsMyocardial infarction inflammatory environment
02

Mechanism of action

Not applicable as this refers to a multi-cellular environment rather than a single molecular target.

03

Biological functions

Immune responseInflammationTissue repairFibrosisAngiogenesisCell-cell communication
04

Disease associations

Cardiovascular diseaseMyocardial infarctionHeart failureMyocarditis
05

Safety considerations

Complexity of multi-cellular interactionsRisk of systemic immunosuppression when targeting cardiac inflammationPotential for impaired wound healing or cardiac rupture if repair pathways are inhibited
06

Biomarkers

Cardiac troponin I/TBrain natriuretic peptide (BNP)Soluble ST2Galectin-3

Beyond the preview

Go deeper on Multiple tissue and immune cell populations in injured myocardium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple tissue and immune cell populations in injured myocardium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call